Claire Friedman discusses the factors clinicians should consider when determining an immunotherapy treatment plan for older patients.
Claire Friedman, MD, Memorial Sloan Kettering Cancer Center, discusses considerations to take when planning immunotherapy treatments for older patients. There is also the possibility of combinations to consider.
When choosing an appropriate immunotherapy agent for an older patient, clinicians should discuss the different options, and their risks and benefits, with patients. Clinicians should keep several factors in mind. Not only are a patient’s lifestyle and medical history important, but so is their social support.
Patients With uHCC Who Experience irAEs With Tremelimumab/Durvalumab Achieve Numerical Improvements in OS
Adding Ribociclib to Endocrine Therapy Yields 25% Relative Reduction in Risk of Invasive Disease In Patients With HR+/HER2– Early Breast Cancer
Simple Hysterectomy May Replace Radical Hysterectomy as Standard of Care in Low-Risk, Early-Stage Cervical Cancer
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis
2 Clarke Drive
Cranbury, NJ 08512